ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/03/29 | 1,469 | 1,481 | 1,452 | 1,452 | -36 | -2.4% | 24,000 |
2013/03/28 | 1,500 | 1,500 | 1,461 | 1,488 | +6 | +0.4% | 27,000 |
2013/03/27 | 1,500 | 1,514 | 1,475 | 1,482 | -45 | -2.9% | 43,000 |
2013/03/26 | 1,490 | 1,527 | 1,489 | 1,527 | +32 | +2.1% | 79,000 |
2013/03/25 | 1,497 | 1,505 | 1,495 | 1,495 | -3 | -0.2% | 35,000 |
2013/03/22 | 1,499 | 1,503 | 1,495 | 1,498 | -1 | -0.1% | 18,000 |
2013/03/21 | 1,491 | 1,500 | 1,488 | 1,499 | +8 | +0.5% | 25,000 |
2013/03/19 | 1,486 | 1,491 | 1,486 | 1,491 | +14 | +0.9% | 13,000 |
2013/03/18 | 1,475 | 1,487 | 1,475 | 1,477 | +2 | +0.1% | 19,000 |
2013/03/15 | 1,470 | 1,476 | 1,470 | 1,475 | +6 | +0.4% | 10,000 |
2013/03/14 | 1,485 | 1,490 | 1,469 | 1,469 | -14 | -0.9% | 16,000 |
2013/03/13 | 1,490 | 1,490 | 1,481 | 1,483 | -1 | -0.1% | 10,000 |
2013/03/12 | 1,489 | 1,490 | 1,481 | 1,484 | -3 | -0.2% | 13,000 |
2013/03/11 | 1,494 | 1,498 | 1,480 | 1,487 | +36 | +2.5% | 24,000 |
2013/03/08 | 1,445 | 1,452 | 1,442 | 1,451 | +4 | +0.3% | 77,000 |
2013/03/07 | 1,440 | 1,448 | 1,440 | 1,447 | +1 | +0.1% | 10,000 |
2013/03/06 | 1,435 | 1,449 | 1,435 | 1,446 | +13 | +0.9% | 13,000 |
2013/03/05 | 1,417 | 1,433 | 1,417 | 1,433 | +16 | +1.1% | 14,000 |
2013/03/04 | 1,410 | 1,428 | 1,408 | 1,417 | +5 | +0.4% | 12,000 |
2013/03/01 | 1,400 | 1,413 | 1,400 | 1,412 | +12 | +0.9% | 20,000 |
2013/02/28 | 1,399 | 1,400 | 1,398 | 1,400 | +7 | +0.5% | 21,000 |
2013/02/27 | 1,398 | 1,398 | 1,390 | 1,393 | -5 | -0.4% | 12,000 |
2013/02/26 | 1,386 | 1,403 | 1,386 | 1,398 | -18 | -1.3% | 17,000 |
2013/02/25 | 1,412 | 1,416 | 1,412 | 1,416 | +4 | +0.3% | 26,000 |
2013/02/22 | 1,400 | 1,417 | 1,395 | 1,412 | -10 | -0.7% | 25,000 |
2013/02/21 | 1,420 | 1,426 | 1,420 | 1,422 | +2 | +0.1% | 18,000 |
2013/02/20 | 1,398 | 1,420 | 1,398 | 1,420 | +30 | +2.2% | 24,000 |
2013/02/19 | 1,387 | 1,393 | 1,386 | 1,390 | +12 | +0.9% | 12,000 |
2013/02/18 | 1,378 | 1,378 | 1,376 | 1,378 | ±0 | ±0% | 9,000 |
2013/02/15 | 1,380 | 1,387 | 1,376 | 1,378 | -4 | -0.3% | 15,000 |
2013/02/14 | 1,384 | 1,395 | 1,381 | 1,382 | +2 | +0.1% | 14,000 |
2013/02/13 | 1,376 | 1,385 | 1,376 | 1,380 | -2 | -0.1% | 10,000 |
2013/02/12 | 1,379 | 1,389 | 1,379 | 1,382 | +7 | +0.5% | 16,000 |
2013/02/08 | 1,388 | 1,388 | 1,375 | 1,375 | -13 | -0.9% | 14,000 |
2013/02/07 | 1,389 | 1,410 | 1,380 | 1,388 | -13 | -0.9% | 20,000 |
2013/02/06 | 1,404 | 1,410 | 1,401 | 1,401 | -16 | -1.1% | 17,000 |
2013/02/05 | 1,430 | 1,430 | 1,417 | 1,417 | -23 | -1.6% | 10,000 |
2013/02/04 | 1,444 | 1,445 | 1,437 | 1,440 | -8 | -0.6% | 9,000 |
2013/02/01 | 1,436 | 1,448 | 1,436 | 1,448 | +12 | +0.8% | 18,000 |
2013/01/31 | 1,442 | 1,446 | 1,436 | 1,436 | -10 | -0.7% | 15,000 |
2013/01/30 | 1,430 | 1,446 | 1,430 | 1,446 | +16 | +1.1% | 13,000 |
2013/01/29 | 1,426 | 1,440 | 1,424 | 1,430 | +3 | +0.2% | 14,000 |
2013/01/28 | 1,432 | 1,445 | 1,423 | 1,427 | +9 | +0.6% | 29,000 |
2013/01/25 | 1,403 | 1,418 | 1,395 | 1,418 | +18 | +1.3% | 25,000 |
2013/01/24 | 1,377 | 1,400 | 1,376 | 1,400 | +19 | +1.4% | 16,000 |
2013/01/23 | 1,382 | 1,385 | 1,371 | 1,381 | -1 | -0.1% | 13,000 |
2013/01/22 | 1,407 | 1,409 | 1,382 | 1,382 | -51 | -3.6% | 21,000 |
2013/01/21 | 1,437 | 1,437 | 1,420 | 1,433 | -4 | -0.3% | 15,000 |
2013/01/18 | 1,400 | 1,440 | 1,400 | 1,437 | +42 | +3% | 18,000 |
2013/01/17 | 1,389 | 1,400 | 1,386 | 1,395 | +15 | +1.1% | 11,000 |
2851~
2900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム